Restart Life Science

Pilz Bioscience Corp. is a biotechnology company based in Vancouver, Canada, that specializes in developing diagnostic and therapeutic solutions for neuro-inflammatory conditions with significant cognitive components and high unmet medical needs. Incorporated in 2020, the company focuses primarily on Autism Spectrum Disorder (ASD) while also addressing conditions such as PTSD, treatment-resistant depression, and anxiety disorders. Pilz employs a systems-level scientific approach that integrates aspects of inflammation and the oral/gut/brain axis to optimize cellular function and modify cognitive perception. The company aims to lead efforts in designing effective diagnostic and monitoring programs, as well as pioneering first-in-class therapeutics in the field of medicinal psychedelics.